Mohit Rawat - Aug 31, 2023 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
President & CBO
Signature
/s/ Maria Stahl as Attorney-in-Fact for Mohit Rawat
Stock symbol
FUSN
Transactions as of
Aug 31, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 08:49 AM
Previous filing
Jan 9, 2023
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FUSN Common Stock Award +12.8K 12.8K Aug 31, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +136K $0.00 136K Jan 4, 2024 Common Stock 136K $8.44 Direct F2
transaction FUSN Restricted Stock Units Award $0 +81.3K $0.00 81.3K Jan 4, 2024 Common Stock 81.3K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan.
F2 This option vests in 48 equal monthly installments beginning on February 4, 2024.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock of Fusion Pharmaceuticals Inc. for no consideration.
F4 The restricted stock units vest in six equal installments on each of July 4, 2024, January 4, 2025, July 4, 2025, January 4, 2026, July 4, 2026 and January 4, 2027.